FC-001: Injected Mushroom Tea and the ICU Case Behind 'Mushrooms in His Blood'
A forensic reconstruction of a 2021 case report in which nonsterile mushroom tea was injected intravenously, followed by bacterial and fungal bloodstream infection, septic shock, respiratory failure, and multiorgan injury.
Failure Chains case file
Intravenous mushroom tea
Reported in 2021
- Outcome
- Septic shock, respiratory failure, disseminated intravascular coagulation, and multiorgan injury; survived
- Primary failure
- Injection of nonsterile biological material directly into the bloodstream
- Source basis
- Single peer-reviewed case report with bacterial and fungal culture identification
- Editorial reading
- The chain describes this incident; it is not a frequency estimate for all exposures.
Failure chain
Therapeutic research was interpreted as support for unsupervised self-treatment
Whole mushroom material was boiled in water and passed through cotton, but not sterilized
The biological liquid was injected directly into a vein
Lethargy, jaundice, gastrointestinal illness, and confusion developed over several days
Bacteremia, fungemia, septic shock, respiratory failure, disordered clotting, and organ injury followed
Eight days of intensive care and 22 total hospital days led to survival
Safety note: This is a documented medical case, not preparation or administration guidance. Confusion, jaundice, blue lips or nail beds, vomiting blood, severe weakness, breathing difficulty, collapse, or signs of shock after an injection or drug exposure are emergencies. Contact emergency services and a poison center immediately rather than waiting for the effects to pass.
Executive Summary
The famous headline says that a man injected mushroom tea and then had “mushrooms growing in his blood.” The documented event was both less cartoonish and more medically serious.
A 30-year-old man injected a homemade liquid prepared from Psilocybe mushrooms. Over the following days, he developed gastrointestinal illness, jaundice, confusion, shock, respiratory failure, abnormal clotting, kidney injury, and liver injury. Blood cultures grew a bacterium identified as Brevibacillus and a fungus identified as Psilocybe cubensis. He spent 22 days in the hospital, including eight days in intensive care, and survived [1].
This was not primarily a conventional psilocybin overdose. Psilocybin's psychedelic pharmacology does not explain bacterial bloodstream infection, fungal culture growth, septic shock, or disseminated intravascular coagulation. The dominant failure was the route: nonsterile biological material was placed directly into the bloodstream, bypassing barriers that normally keep environmental organisms out.
The case is valuable because it separates three things that are often blurred together:
- a psychoactive molecule,
- the biological material containing it,
- and the route used to introduce that material into the body.
Those are not interchangeable.
The Story
The case report described a 30-year-old man with bipolar I disorder and a history of injection drug use. He had been reading about experimental psychedelic research while looking for ways to address depression and opioid dependence [1].
The crucial misunderstanding was not merely that he believed psilocybin might have therapeutic potential. That question is being studied under controlled conditions. The failure was treating research on carefully prepared interventions as permission to improvise an injectable product from whole mushrooms.
He boiled psilocybin-containing mushrooms in water, passed the resulting liquid through cotton, and injected it intravenously. Cotton can catch visible particles. It does not reliably remove bacteria, fungal cells, spores, dissolved contaminants, or toxins, and it does not convert a kitchen preparation into a sterile pharmaceutical product.
Over the next several days, the man became lethargic and jaundiced. He developed diarrhea, nausea, and hematemesis—vomiting blood. His family eventually found him confused and brought him to an emergency department [1].
On examination, he appeared severely ill. The report described dry mucous membranes, mild blue discoloration of the lips and nail beds, jaundiced skin, diffuse abdominal tenderness, low blood pressure, and confusion severe enough that he could not participate meaningfully in an interview.
Laboratory testing showed abnormalities across several systems, including low platelets, electrolyte disturbances, acute kidney dysfunction, acute liver injury, and elevated cardiac enzymes. The electrocardiogram showed sinus tachycardia and early repolarization. The accumulating picture was not simply intoxication or a prolonged psychedelic experience. It was multiorgan failure.
He was transferred to intensive care and treated with intravenous fluids, vasopressors to support blood pressure, broad-spectrum antibacterial drugs, and antifungal medication. His condition progressed to septic shock and acute respiratory failure. He required intubation on the second hospital day. He also developed disseminated intravascular coagulation, a dangerous state in which uncontrolled activation of clotting can produce both microscopic clots and severe bleeding. The report states that plasmapheresis was used [1].
Blood cultures identified Brevibacillus bacteremia and growth identified as Psilocybe cubensis fungemia. He remained hospitalized for 22 days, eight of them in intensive care. At the time of publication, the authors reported that he remained on a prolonged regimen of antibacterial and antifungal therapy [1].
What the Source Documented
Documented
The peer-reviewed report documented:
- self-reported intravenous injection of a liquid made from psilocybin-containing mushrooms,
- several days of progressive illness,
- hypotension, confusion, cyanosis, jaundice, and abdominal tenderness,
- kidney, liver, electrolyte, platelet, and cardiac-marker abnormalities,
- septic shock and respiratory failure requiring intensive care and intubation,
- disseminated intravascular coagulation,
- blood cultures reported as Brevibacillus and Psilocybe cubensis,
- and survival after a 22-day hospitalization [1].
Inferred
The strongest inference is that direct inoculation of contaminated biological material drove the bloodstream infections and septic physiology. The timing, route, culture findings, and clinical syndrome all support that interpretation.
It is also reasonable to infer that the cotton filtration step created false confidence. It reduced visible material without solving sterility.
Uncertain
The brief report does not establish:
- the exact quantity of mushroom material or psilocybin involved,
- the organisms present in the liquid before injection,
- whether contamination came from the mushrooms, water, preparation environment, cotton, syringe, skin, or several sources,
- the detailed laboratory method used to identify the cultured fungus,
- the exact contribution of the bacterium, fungus, inflammatory response, dehydration, and other factors to each organ injury,
- or whether any acute psychedelic effects materially changed the subsequent clinical course.
Those gaps matter. A memorable story is not permission to invent missing microbiology.
What “Mushrooms Growing in His Blood” Actually Means
The popular phrase creates an image of mushroom caps or fruiting bodies sprouting inside veins. That is not what the case report described.
A blood culture places a blood sample into conditions designed to reveal whether viable microorganisms are present. Organisms that reproduce in that laboratory culture can then be identified. In this case, the authors reported fungal growth identified as Psilocybe cubensis [1].
That supports the presence of viable fungal material in the sampled blood. It does not mean that recognizable mushrooms were physically fruiting inside the patient's circulation.
There is another reason to use careful wording: the published report is only two pages long and does not provide a detailed account of the fungal-identification method. The core claim is credible enough to report as the authors' finding, but the evidence does not justify embellishing it into a body-horror metaphor.
The scientifically accurate version is already extraordinary:
Following injection of a homemade mushroom preparation, blood cultures grew organisms identified as a bacterium and the injected mushroom species.
No tabloid garnish required.
Pharmacology and Toxicology
Psilocybin is converted in the body to psilocin, which produces psychedelic effects largely through serotonin 5-HT2A receptor activity. That mechanism can alter perception, cognition, emotion, and sense of self. It does not produce Brevibacillus bacteremia.
Researchers may administer purified compounds through routes chosen under strict protocols. A sterile, chemically characterized research formulation is fundamentally different from whole fungal tissue boiled in a nonsterile setting. Sharing the word “intravenous” does not make the exposures pharmacologically or microbiologically comparable.
The gastrointestinal tract, skin, liver, and immune system provide layers of protection and processing. Intravenous injection bypasses several of those defenses and gives contaminants immediate access to circulation. Once organisms or microbial products enter the bloodstream, the immune response can become systemic. Blood vessels dilate, pressure falls, tissue perfusion fails, clotting becomes disordered, and organs begin to malfunction. That sequence is sepsis—not an unusually intense trip.
Earlier literature shows that intravenous mushroom extracts had caused severe systemic illness before the 2021 report. A 1985 case described vomiting, severe muscle pain, extreme fever, low blood oxygen, and mild methemoglobinemia after intravenous exposure to a Psilocybe extract; the patient improved with supportive care [2]. A short 1984 report also documented intravenous mushroom injection [3].
Those older cases do not prove that every event followed the same mechanism. They do show that this route had already produced medical emergencies and that the 2021 event was not the first warning.
Failure-Chain Analysis
1. Therapeutic possibility became personal permission
Research suggesting potential benefits under controlled conditions was translated into a do-it-yourself intervention. This is a common information failure: a finding about a molecule, formulation, population, and clinical setting is stripped of those boundaries.
2. The molecule was confused with the organism
Purified psilocybin is a chemical. A mushroom is living biological material containing many chemicals, cellular structures, microorganisms, and environmental contaminants. Extracting some compounds into water does not erase the rest of that biology.
3. Filtration was confused with sterilization
Removing visible particles can make a liquid look cleaner without making it microbiologically safe. Visual clarity is not evidence of sterility.
4. Intravenous delivery removed the body's margin for error
Swallowed contaminants face barriers and processing. Injected contaminants reach circulation directly. The route transformed a dubious preparation into a high-consequence exposure.
5. Progressive illness unfolded over days
The delay between injection and obvious collapse may have obscured the seriousness of the event. By the time emergency care began, multiple organ systems were already involved.
No single receptor explains this chain. It was a translation failure, formulation failure, sterility failure, route failure, and delayed medical crisis stacked together.
Emergency Response
Clinicians approached the patient as critically ill rather than assuming that confusion after a psychedelic exposure was merely psychiatric. That distinction was lifesaving.
The medical response addressed the physiology that was failing:
- fluids and vasopressors for shock,
- antibacterial and antifungal treatment for suspected bloodstream infection,
- airway and ventilatory support for respiratory failure,
- intensive monitoring of kidney, liver, cardiac, electrolyte, platelet, and clotting abnormalities,
- and treatment of disseminated intravascular coagulation [1].
This is an important emergency-medicine lesson. When altered mental status appears alongside jaundice, cyanosis, bleeding, hypotension, fever, breathing difficulty, or organ injury, “bad trip” is not an adequate diagnosis. The psychoactive exposure may be only one part of the problem—or almost beside the point.
Could This Have Been Prevented?
Preventability: very high.
The critical event was not an unpredictable reaction at an ordinary route of exposure. It was direct injection of a nonsterile biological preparation. Avoiding that action would very probably have prevented the bacteremia, fungemia, and septic shock described in the report.
That judgment does not mean every downstream detail was predictable. The exact organisms and organ complications were not. The high-level hazard was.
The broad prevention lesson is simple:
Evidence that a psychoactive molecule may have therapeutic potential does not make homemade biological material safe for injection.
Evidence Quality and Uncertainty
The 2021 source is a peer-reviewed case report, which is appropriate for documenting a rare event but weak for estimating frequency or proving general rules. Its strengths include a coherent clinical timeline, severe objective findings, intensive-care treatment, and reported bacterial and fungal culture identification [1].
Its limitations include:
- reliance on self-report for preparation and exposure history,
- no retained sample of the injected liquid for analysis,
- sparse description of microbiological identification methods,
- no comparison group,
- and no way to separate precisely the contribution of every infectious, toxic, inflammatory, and psychiatric factor.
The earlier 1984 and 1985 reports strengthen the conclusion that intravenous mushroom preparations can produce severe systemic illness [2, 3]. They do not make the 2021 case common, nor do they establish the probability of a particular complication.
The correct confidence statement is therefore two-part:
- Moderate confidence that the reported incident occurred substantially as described.
- Low confidence in any claim about how often the same outcome would occur.
Bigger Questions
- How should researchers communicate promising therapeutic findings so readers do not mistake controlled formulations for interchangeable homemade products?
- What minimum microbiology detail should unusual fungemia case reports publish to make species identification independently assessable?
- Why does visible filtration feel intuitively equivalent to safety, even when microorganisms are invisible?
- How can harm-reduction education discuss route-specific danger without accidentally supplying operational instructions?
- How often do emergency clinicians encounter severe complications from improvised formulations that never become published case reports?
Related Reading
For the broader pattern—misidentification, delayed onset, unusual routes, delirium, and hidden toxicology—see When the Label Lies: Eight Hallucinogen Disasters and the Failure Chains Behind Them.